Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Background/AimsNonselective β-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB m...

Full description

Bibliographic Details
Main Authors: Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2012-06-01
Series:Clinical and Molecular Hepatology
Subjects:
Nonselective β-blockers
Liver cirrhosis
Overall survival
Child-Turcotte-Pugh
Online Access:http://e-cmh.org/upload/pdf/cmh-18-203.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-18-203.pdf

Similar Items